When the FDA removed GLP-1s from the shortage list, many were unsure whether compounded versions could still be prescribed. In this episode, hosts Brad and Michael share the story of a medical weight loss clinic and the fallout after these drugs were removed from the shortage list. Tune in to learn how regulatory shifts, misinformation, and risk management collide in modern medicine. Find out how practices can navigate evolving regulations and avoid pitfalls when prescribing compounded weight loss drugs.

Chapters

00:00 Intro  

00:50 Banter  

04:34 Story  

17:18 Access+  

17:48 Legal Takeaways  

30:07 Outro

Watch full episodes of our podcast on our YouTube channel: https://www.youtube.com/@byrdadatto  
Stay connected for the latest business and health care legal updates:
Website
Facebook
Instagram
LinkedIn